2,4-Di­amino­pyrimidine derivatives have also shown effective suppression of anaplastic lymphoma kinase (ALK), one of the receptor tyrosine kinases that is involved in a variety of tumours (Achary et al., 2017 ▸). Here, ALK is linked to neoplasm.